Line 164: | Line 164: | ||
<div class="row"> | <div class="row"> | ||
− | <div class="col-sm-12 pagetext"> | + | <div class="col-sm-12 pagetext"> |
</div> <!--END col-sm-12--> | </div> <!--END col-sm-12--> | ||
</div> | </div> | ||
Line 172: | Line 172: | ||
<div class="row rowT"> | <div class="row rowT"> | ||
<div class="col-sm-12 col-PT"> | <div class="col-sm-12 col-PT"> | ||
− | <h1 class="sectionTitle-R"> | + | <h1 class="sectionTitle-R">Experimental Design</h1> |
</div> | </div> | ||
</div> <!--END rowT--> | </div> <!--END rowT--> | ||
Line 182: | Line 182: | ||
<img src="https://static.igem.org/mediawiki/2016/4/44/T--Stanford-Brown--PlaceholderImage.png" class="img-L"> | <img src="https://static.igem.org/mediawiki/2016/4/44/T--Stanford-Brown--PlaceholderImage.png" class="img-L"> | ||
</div> <!--END col-sm-5--> | </div> <!--END col-sm-5--> | ||
− | <div class="col-sm-7 pagetext-R"><div class="text"> | + | <div class="col-sm-7 pagetext-R"><div class="text">In order to appropriate enhanced IPP and subsequently latex precursor production, we took advantage of E. coli's endogenous MEP pathway, and implemented an HMG-CoA reductase pathway for enhanced IPP production. Both pathways result in the production of IPP and its isomer, DMAPP. However, the HMG-CoA pathway is exogenous to E. coli and was needed for enhanced production of IPP. While the MEP pathway converts pyruvate and G3P into IPP/DMAPP through a seven step process, the HMG-CoA (MVA) pathway converts acetyl CoA into IPP/DMAPP through a six step process. Both pathways employ the use of metabolic products produced and used by glycolysis and cellular respiration (calvin cycle); hence enhanced expression of these pathways is expected to affect cellular growth and development. </div> |
</div> <!--END col-sm-7--> | </div> <!--END col-sm-7--> | ||
</div> <!--END row--> | </div> <!--END row--> |
Revision as of 18:47, 9 October 2016
Experimental Design
INSERT INTRO HERE
Experimental Design
In order to appropriate enhanced IPP and subsequently latex precursor production, we took advantage of E. coli's endogenous MEP pathway, and implemented an HMG-CoA reductase pathway for enhanced IPP production. Both pathways result in the production of IPP and its isomer, DMAPP. However, the HMG-CoA pathway is exogenous to E. coli and was needed for enhanced production of IPP. While the MEP pathway converts pyruvate and G3P into IPP/DMAPP through a seven step process, the HMG-CoA (MVA) pathway converts acetyl CoA into IPP/DMAPP through a six step process. Both pathways employ the use of metabolic products produced and used by glycolysis and cellular respiration (calvin cycle); hence enhanced expression of these pathways is expected to affect cellular growth and development.
Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here. Stanford-Brown iGEMmers paste your contributions here.